MI CARES addresses opioid crisis, helps create more Addiction Medicine specialists

It can start with something as simple as needing pain medicine after surgery and eventually turn into an addiction. For some, it can lead to death.

There's an opioid epidemic in Michigan. In an effort to address it and meet the demand for more Addiction Medicine specialists, Spectrum Health, Michigan State University, University of Michigan, and Wayne State University have created the Michigan Collaborative Addiction Resources and Education System (MI CARES).

Dr. Cara Poland from Spectrum Health Medical Group Maternal Fetal Medicine, explains what MI CARES is, and how they're helping those in the community with addiction.

In 2017, Michigan recorded nearly 2,000 opioid-related deaths, according to MDHHS. By some measures, Michigan is in the top 10, according to Dr. Poland.

According to Michigan State University, there are less than 200 physicians certified in addiction medicine and only one physician practices in the Upper Peninsula.

MI CARES identifies physicians and guides them through the Practice Pathway, a method created by The American Board of Medical Specialties (ABMS) to allow more providers to gain experience in new specialties without a fellowship.

Providers interested in enrolling must have an unrestricted and current medical license, a medical degree and a board certification by any ABMS Board.

For more information, visit micares.msu.edu.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s


  • Sandi McCarthy

    This is fantastic. Every Physician, with the proper qualifications, should enroll in this program. The Opiod crisis may be able to be curtailed but as history has proven, addiction never really gets “cured”. Something else will come along. The more education and training programs like this can provide the better the outcome…more people can be treated and live productive lives. It’s so very important that our Doctors get on board with this. Thank you for being part of the Solution!!

  • Evan Kearney

    This better not be more than something to get me hopeful that the demonization of OUD is over. If it is, I will be even more dejected and withdrawaen from our species’ failures to get off its moralistic obesession. Morals are not needed here, except in malpractice and in proper cleaning of instruments. You see the silly bifurcation. OUD and SUD is the only class of disorder/illness/whatever you want to call it (“Thing People Don’t Like”) for which ANY controversy over treatment exists, when Buprenorphine is pretty good at both the suppression of craving (MU-Partial Agonist (38%), Kappa-Antagonist (well P.A. of about 4%), and most importantly IMO Nociceptin-Receptor Partial Agonist of 12-18% depending on the assay used). This is perfect! Combats the cravings, the hatred of other people, the rage, the tiredness, etc. But better yet, why not use Morphine Sulfate XR tablets. They are very effective in Maintenance in some Euro-countries for treatment-refractory OUD patients. They might be more troubled by cravings (since Morphine is a MU full agonist). Heck, what other disorder-class has only three drugs to choose from? Especially when milions of poeple suffer from it, and its not terminal. Of course it IS terminal when you don’t expand the treatment options to really creative stuff like “Transferance-Based Psychotherapy” only after a strong dose of a Kappa-Antagonist, say. All neuroscientists know this already. The public is just plain MEAN.

    Yup. I have committed typos and mild syntactical errors. I don’t feel like correcting them. So bust away. It reveals how petty you are.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.